Index RUT
P/E -
EPS (ttm) -1.15
Insider Own 16.33%
Shs Outstand 159.26M
Perf Week 1.69%
Market Cap 1.53B
Forward P/E -
EPS next Y -1.39
Insider Trans -0.31%
Shs Float 133.28M
Perf Month 15.49%
Enterprise Value 1.26B
PEG -
EPS next Q -0.35
Inst Own 74.32%
Short Float 10.82%
Perf Quarter 31.06%
Income -192.71M
P/S 25.69
EPS this Y -17.19%
Inst Trans 3.54%
Short Ratio 6.72
Perf Half Y 15.21%
Sales 59.65M
P/B 5.76
EPS next Y 2.56%
ROA -40.79%
Short Interest 14.42M
Perf YTD 12.65%
Book/sh 1.67
P/C 4.38
EPS next 5Y 4.11%
ROE -57.19%
52W High 11.77 -18.30%
Perf Year 44.44%
Cash/sh 2.20
P/FCF -
EPS past 3/5Y -7.77% 8.51%
ROIC -56.68%
52W Low 5.78 66.29%
Perf 3Y 153.83%
Dividend Est. -
EV/EBITDA -
Sales past 3/5Y 13.55% 72.05%
Gross Margin 90.67%
Volatility 5.20% 5.73%
Perf 5Y 17.17%
Dividend TTM -
EV/Sales 21.11
EPS Y/Y TTM -3.59%
Oper. Margin -342.15%
ATR (14) 0.52
Perf 10Y -58.41%
Dividend Ex-Date -
Quick Ratio 10.14
Sales Y/Y TTM -0.33%
Profit Margin -323.09%
RSI (14) 65.38
Recom 1.08
Dividend Gr. 3/5Y - -
Current Ratio 10.22
EPS Q/Q 23.03%
SMA20 8.04%
Beta 1.48
Target Price 17.92
Payout -
Debt/Eq 0.29
Sales Q/Q -27.59%
SMA50 17.77%
Rel Volume 0.54
Prev Close 9.46
Employees 274
LT Debt/Eq 0.28
Earnings May 05 BMO
SMA200 13.46%
Avg Volume 2.15M
Price 9.62
IPO Jul 25, 2014
Option/Short Yes / Yes
EPS/Sales Surpr. -29.08% -37.15%
Trades
Volume 1,158,808
Change 1.69%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-08-25 Initiated
William Blair
Outperform
Mar-18-25 Initiated
RBC Capital Mkts
Outperform
$17
Mar-11-25 Initiated
Needham
Buy
$15
Oct-16-24 Initiated
Scotiabank
Sector Outperform
Jun-20-24 Upgrade
TD Cowen
Hold → Buy
$7 → $11
May-31-24 Resumed
Piper Sandler
Overweight
$15
Feb-09-24 Initiated
BofA Securities
Buy
$15
Apr-21-23 Initiated
Robert W. Baird
Outperform
$18
Aug-10-22 Resumed
Berenberg
Buy
$15
Aug-10-21 Upgrade
H.C. Wainwright
Neutral → Buy
$17
Dec-28-20 Downgrade
H.C. Wainwright
Buy → Neutral
Dec-17-20 Initiated
Berenberg
Buy
$27
Nov-13-20 Reiterated
Raymond James
Strong Buy
$15 → $25
Aug-10-20 Reiterated
H.C. Wainwright
Buy
$10 → $13
Mar-03-20 Upgrade
Raymond James
Outperform → Strong Buy
May-21-19 Reiterated
H.C. Wainwright
Buy
$12 → $9
May-21-19 Downgrade
Raymond James
Strong Buy → Outperform
$11 → $5
May-21-19 Downgrade
Cowen
Outperform → Market Perform
$13 → $3
Dec-03-18 Reiterated
Cantor Fitzgerald
Overweight
$22 → $24
Nov-15-18 Initiated
Raymond James
Strong Buy
$10
Show Previous Ratings
Jun-26-25 01:54PM
Jun-25-25 11:13AM
Jun-16-25 07:00AM
May-28-25 07:00AM
May-14-25 07:00AM
08:15AM
Loading…
May-05-25 08:15AM
07:11AM
(Associated Press Finance)
07:00AM
May-02-25 09:25AM
Apr-29-25 10:01AM
07:00AM
Apr-28-25 07:00AM
Apr-11-25 04:30PM
(GlobeNewswire) +11.01%
+6.47%
Mar-31-25 07:00AM
Mar-14-25 08:36AM
02:49PM
Loading…
Mar-11-25 02:49PM
Mar-07-25 04:05PM
Mar-04-25 02:00AM
Mar-03-25 11:41PM
(Thomson Reuters StreetEvents) -17.02%
08:15AM
07:19AM
(Associated Press Finance)
07:00AM
Feb-28-25 07:10AM
Feb-25-25 07:00AM
Feb-24-25 07:00AM
Feb-03-25 07:00AM
Jan-17-25 07:00AM
Jan-14-25 07:00AM
Jan-08-25 07:00AM
Dec-13-24 07:00AM
07:30AM
Loading…
Dec-10-24 07:30AM
Dec-03-24 07:47AM
Dec-02-24 07:30AM
Nov-26-24 07:30AM
Nov-15-24 02:06AM
Nov-14-24 08:40AM
07:37AM
(Associated Press Finance)
07:00AM
Nov-13-24 07:30AM
07:17AM
Nov-12-24 07:30AM
Nov-06-24 07:30AM
Oct-15-24 07:30AM
Oct-14-24 09:59AM
Oct-09-24 04:05PM
07:30AM
Oct-08-24 08:50AM
Sep-25-24 07:30AM
Sep-12-24 04:05PM
Sep-05-24 07:30AM
Sep-04-24 07:30AM
Aug-09-24 09:55AM
07:30AM
Aug-07-24 08:45AM
07:38AM
(Associated Press Finance)
07:10AM
07:00AM
Jul-31-24 07:30AM
Jul-30-24 07:30AM
Jul-18-24 04:05PM
Jul-10-24 08:00AM
Jul-08-24 04:05PM
Jun-13-24 04:05PM
Jun-05-24 07:30AM
Jun-04-24 04:05PM
May-07-24 09:01PM
06:07PM
04:41PM
(Associated Press Finance)
04:05PM
May-06-24 08:16PM
07:30AM
May-03-24 07:30AM
May-01-24 07:30AM
Apr-24-24 08:30AM
Apr-18-24 03:37PM
07:00AM
Apr-16-24 04:30PM
07:00AM
Apr-15-24 07:00AM
Apr-09-24 09:35AM
07:30AM
Apr-06-24 10:00AM
Apr-01-24 10:09AM
Mar-26-24 07:30AM
Mar-13-24 06:38AM
(Thomson Reuters StreetEvents)
Mar-12-24 09:55AM
Mar-11-24 05:32PM
05:25PM
04:26PM
(Associated Press Finance)
04:05PM
Mar-05-24 07:30AM
Mar-01-24 06:30PM
Feb-29-24 08:52AM
Feb-28-24 01:40PM
Feb-26-24 12:00PM
10:00AM
Feb-25-24 02:02PM
Feb-22-24 07:32AM
07:31AM
07:30AM
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Waheed Nadia Chief Medical Officer Jun 02 '25 Sale 8.05 13,861 111,581 206,805 Jun 03 04:20 PM NADIA K. WAHEED Officer Jun 02 '25 Proposed Sale 8.05 13,861 111,524 Jun 02 04:40 PM Nayak Sanjay Chief Strategy Officer May 23 '25 Sale 7.17 1,862 13,351 281,623 May 27 05:42 PM Kaiser Peter Chief Development Officer May 23 '25 Sale 7.17 2,974 21,324 207,104 May 27 05:40 PM Heier Jeffrey S. Chief Scientific Officer May 23 '25 Sale 7.18 3,024 21,712 262,974 May 27 05:39 PM Dugel Pravin See Remarks May 23 '25 Sale 7.18 21,219 152,352 3,499,099 May 27 05:37 PM PETER KAZUO KAISER Officer May 23 '25 Proposed Sale 7.17 2,974 21,323 May 23 04:14 PM JEFFREY S. HEIER Officer May 23 '25 Proposed Sale 7.18 3,024 21,707 May 23 04:11 PM PRAVIN DUGEL Officer May 23 '25 Proposed Sale 7.18 21,219 152,289 May 23 04:08 PM SANJAY NAYAK Officer May 23 '25 Proposed Sale 7.17 1,862 13,347 May 23 04:07 PM LINDSTROM RICHARD L MD Director May 08 '25 Buy 6.96 10,000 69,600 172,704 May 12 08:50 PM Dugel Pravin See Remarks Feb 24 '25 Sale 6.87 21,475 147,533 3,520,318 Feb 26 06:27 PM Heier Jeffrey S. Chief Scientific Officer Feb 24 '25 Sale 6.87 3,061 21,029 265,998 Feb 26 06:25 PM Kaiser Peter Chief Development Officer Feb 24 '25 Sale 6.87 3,009 20,672 210,078 Feb 26 06:24 PM Nayak Sanjay Chief Strategy Officer Feb 24 '25 Sale 6.84 1,895 12,962 283,485 Feb 26 06:22 PM PETER KAZUO KAISER Officer Feb 24 '25 Proposed Sale 6.87 3,009 20,684 Feb 24 04:54 PM JEFFREY S. HEIER Officer Feb 24 '25 Proposed Sale 6.87 3,061 21,043 Feb 24 04:33 PM PRAVIN DUGEL Officer Feb 24 '25 Proposed Sale 6.87 21,475 147,617 Feb 24 04:32 PM SANJAY NAYAK Officer Feb 24 '25 Proposed Sale 6.84 1,895 12,957 Feb 24 04:30 PM Notman Donald See Remarks Feb 04 '25 Sale 7.81 11,119 86,839 193,444 Feb 04 07:16 PM Notman Donald See Remarks Jan 31 '25 Sale 7.84 6,301 49,400 204,563 Feb 04 07:16 PM DONALD D NOTMAN JR. Officer Feb 04 '25 Proposed Sale 7.81 11,119 86,809 Feb 04 04:24 PM DONALD D NOTMAN JR. Officer Jan 31 '25 Proposed Sale 7.84 6,301 49,404 Jan 31 04:24 PM Heier Jeffrey S. Chief Scientific Officer Nov 25 '24 Sale 9.01 2,948 26,561 269,059 Nov 27 07:52 AM Kaiser Peter Chief Development Officer Nov 25 '24 Sale 9.01 2,897 26,102 213,087 Nov 27 07:51 AM Nayak Sanjay Chief Strategy Officer Nov 25 '24 Sale 9.00 1,814 16,326 174,380 Nov 27 07:49 AM Dugel Pravin See Remarks Nov 25 '24 Sale 9.01 20,680 186,327 791,793 Nov 27 07:47 AM SANJAY NAYAK Officer Nov 25 '24 Proposed Sale 8.97 1,814 16,273 Nov 25 06:42 PM PETER KAZUO KAISER Officer Nov 25 '24 Proposed Sale 9.01 2,897 26,095 Nov 25 06:23 PM PRAVIN DUGEL Officer Nov 25 '24 Proposed Sale 9.01 17,783 160,186 Nov 25 06:19 PM PRAVIN DUGEL Officer Nov 25 '24 Proposed Sale 9.01 2,897 26,095 Nov 25 05:44 PM JEFFREY S. HEIER Officer Nov 25 '24 Proposed Sale 9.01 2,948 26,550 Nov 25 05:10 PM PHILIP C. STRASSBURGER Officer Oct 16 '24 Proposed Sale 10.23 13,125 134,269 Oct 16 04:25 PM Nayak Sanjay Chief Strategy Officer Aug 23 '24 Sale 9.02 1,832 16,525 176,194 Aug 27 05:19 PM Dugel Pravin See Remarks Aug 23 '24 Sale 9.02 20,880 188,338 812,473 Aug 27 05:17 PM RABIA OZDEN Officer Aug 27 '24 Proposed Sale 9.00 18,333 164,997 Aug 27 04:18 PM PRAVIN DUGEL Officer Aug 23 '24 Proposed Sale 9.02 20,880 188,271 Aug 23 05:10 PM SANJAY NAYAK Officer Aug 23 '24 Proposed Sale 9.02 1,832 16,526 Aug 23 04:36 PM RABIA OZDEN Officer Aug 21 '24 Proposed Sale 8.90 10,000 89,047 Aug 21 05:32 PM RABIA OZDEN Officer Aug 07 '24 Proposed Sale 8.50 15,000 127,500 Aug 07 04:15 PM ANTONY MATTESSICH Former Officer Aug 01 '24 Proposed Sale 8.19 23,979 196,498 Aug 01 04:30 PM